News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Infinity Group Invests 120 Million RMB in Shijiazhuang Xingbai Pharmaceutical Company Limited, China



3/1/2011 10:14:10 AM

SHIJIAZHUANG (SJZ), China & TEL AVIV, Israel--(BUSINESS WIRE)--Infinity Group, an RMB fund pioneer and the leader in cross border China RMB and dollar private equity funds, announced today that it is investing 120 million RMB ($US18 million) in Shijiazhuang Xingbai Pharmaceutical Company Limited. Four of Infinity’s funds - the SJZ fund, the I-China fund, the Changzhou fund and the Tianjin fund - participated in this investment. The financing is earmarked to enhance Shijiazhuang Xingbai’s bio-tech capabilities with the goal of better competing on domestic and international markets. Shijiazhuang Xingbai is planning an IPO in the A-share market in three years.

Read at BioSpace.com
Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES